
CervoMed Inc.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
CervoMed Inc. is a clinical-stage pharmaceutical company developing therapies for neurodegenerative diseases, including dementia with Lewy bodies and other age-related cognitive disorders.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| ALAM JOHN JCEO & President | Buy | $117K | 76,319at $1.53 | Nov 18, 2026 |
| ALAM JOHN JCEO & President | Buy | $36K | 23,681at $1.51 | Nov 18, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable CRVO activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.